2022 (v1)
Publication
No description
Uploaded on: February 14, 2024
-
-
2022 (v1)Publication
Background and purpose: The prevention of disability over the long term is the main treatment goal in multiple sclerosis (MS); however, randomized clinical trials evaluate only short-term treatment effects on disability. This study aimed to define criteria for 6-month confirmed disability progression events of MS with a high probability of...
Uploaded on: April 14, 2023 -
October 13, 2021 (v1)Publication
Introduction: Multiple sclerosis (MS) treatment interruptions are common and leave patients vulnerable to breakthrough disease activity. The safe duration of the 'switchover time' for different therapies is not known.Aims: To evaluate the rate and predictors of return of disease activity after cessation of disease-modifying therapy.Methods:...
Uploaded on: November 8, 2024 -
August 17, 2022 (v1)Journal article
Objectives: To evaluate the rate of return of disease activity after cessation of multiple sclerosis (MS) disease-modifying therapy. Methods: This was a retrospective cohort study from two large observational MS registries: MSBase and OFSEP. Patients with relapsing-remitting MS who had ceased a disease-modifying therapy and were followed up for...
Uploaded on: December 3, 2022